BCRX logo

BioCryst Pharmaceuticals, Inc. (BCRX) Cost of goods sold

annual cost of goods sold:

$13.73M+$7.42M(+117.40%)
December 31, 2024

Summary

  • As of today (September 5, 2025), BCRX annual cost of goods sold is $13.73 million, with the most recent change of +$7.42 million (+117.40%) on December 31, 2024.
  • During the last 3 years, BCRX annual cost of goods sold has risen by +$5.69 million (+70.76%).
  • BCRX annual cost of goods sold is now at all-time high.

Performance

BCRX Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXincome statement metrics

quarterly cost of goods sold:

$3.13M-$1.77M(-36.17%)
June 30, 2025

Summary

  • As of today (September 5, 2025), BCRX quarterly cost of goods sold is $3.13 million, with the most recent change of -$1.77 million (-36.17%) on June 30, 2025.
  • Over the past year, BCRX quarterly cost of goods sold has increased by +$1.07 million (+52.24%).
  • BCRX quarterly cost of goods sold is now -79.44% below its all-time high of $15.21 million, reached on December 31, 2011.

Performance

BCRX quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXincome statement metrics

TTM cost of goods sold:

$18.00M+$1.07M(+6.34%)
June 30, 2025

Summary

  • As of today (September 5, 2025), BCRX TTM cost of goods sold is $18.00 million, with the most recent change of +$1.07 million (+6.34%) on June 30, 2025.
  • Over the past year, BCRX TTM cost of goods sold has increased by +$10.64 million (+144.37%).
  • BCRX TTM cost of goods sold is now -68.70% below its all-time high of $57.52 million, reached on December 31, 2011.

Performance

BCRX TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXincome statement metrics

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

BCRX Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+117.4%+52.2%+144.4%
3 y3 years+70.8%+437.3%+600.3%
5 y5 years+234.8%--

BCRX Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+117.4%-51.4%+437.3%at high+600.3%
5 y5-yearat high+719.3%-51.4%+1098.1%at high+768.1%
alltimeall timeat high+2388.5%-79.4%+1663.5%-68.7%+3701.0%

BCRX Cost of goods sold History

DateAnnualQuarterlyTTM
Jun 2025
-
$3.13M(-36.2%)
$18.00M(+6.3%)
Mar 2025
-
$4.90M(-23.9%)
$16.93M(+23.3%)
Dec 2024
$13.73M(+117.4%)
$6.44M(+82.0%)
$13.73M(+46.8%)
Sep 2024
-
$3.54M(+72.3%)
$9.35M(+26.9%)
Jun 2024
-
$2.05M(+21.0%)
$7.37M(+10.4%)
Mar 2024
-
$1.70M(-17.6%)
$6.67M(+5.6%)
Dec 2023
$6.32M(-21.4%)
$2.06M(+32.4%)
$6.32M(-11.6%)
Sep 2023
-
$1.56M(+14.7%)
$7.15M(-25.5%)
Jun 2023
-
$1.36M(+1.0%)
$9.59M(+8.8%)
Mar 2023
-
$1.34M(-53.6%)
$8.82M(+9.8%)
Dec 2022
$8.03M(-0.1%)
$2.89M(-27.7%)
$8.03M(+40.2%)
Sep 2022
-
$4.00M(+587.6%)
$5.73M(+122.8%)
Jun 2022
-
$582.00K(+4.9%)
$2.57M(+1.6%)
Mar 2022
-
$555.00K(-5.9%)
$2.53M(-68.5%)
Dec 2021
$8.04M(+379.8%)
$590.00K(-30.1%)
$8.04M(+4.3%)
Sep 2021
-
$844.00K(+55.7%)
$7.71M(-8.1%)
Jun 2021
-
$542.00K(-91.1%)
$8.39M(+6.9%)
Mar 2021
-
$6.07M(+2223.8%)
$7.85M(+278.6%)
Dec 2020
$1.68M(-59.1%)
$261.00K(-82.9%)
$2.07M(-52.7%)
Sep 2020
-
$1.53M(+431.7%)
$4.38M(+34.3%)
Mar 2020
-
$287.00K(-88.8%)
$3.27M(-26.9%)
Dec 2019
$4.10M(+379.1%)
$2.57M(+1185.5%)
$4.46M(+113.1%)
Sep 2019
-
$200.00K(-3.4%)
$2.10M(-0.6%)
Jun 2019
-
$207.00K(-86.1%)
$2.11M(-1.7%)
Mar 2019
-
$1.49M(+635.6%)
$2.14M(+140.6%)
Dec 2018
$856.00K(-49.7%)
$202.00K(-5.2%)
$891.00K(-2.0%)
Sep 2018
-
$213.00K(-12.3%)
$909.00K(-53.5%)
Jun 2018
-
$243.00K(+4.3%)
$1.95M(+2.6%)
Mar 2018
-
$233.00K(+5.9%)
$1.90M(-3.1%)
Dec 2017
$1.70M(-36.9%)
$220.00K(-82.5%)
$1.97M(-53.2%)
Sep 2017
-
$1.26M(+547.9%)
$4.20M(+32.4%)
Jun 2017
-
$194.00K(-34.0%)
$3.17M(+2.5%)
Mar 2017
-
$294.00K(-88.0%)
$3.09M(+7.5%)
Dec 2016
$2.70M(+42.4%)
$2.45M(+963.8%)
$2.88M(+507.9%)
Sep 2016
-
$230.50K(+98.7%)
$473.00K(-70.3%)
Jun 2016
-
$116.00K(+50.6%)
$1.59M(-17.0%)
Mar 2016
-
$77.00K(+55.6%)
$1.92M(+0.1%)
Dec 2015
$1.90M(+800.7%)
$49.50K(-96.3%)
$1.92M(+0.3%)
Sep 2015
-
$1.35M(+205.7%)
$1.91M(+218.1%)
Jun 2015
-
$442.00K(+489.3%)
$601.00K(+188.9%)
Mar 2015
-
$75.00K(+70.5%)
$208.00K(+1.0%)
Dec 2014
$210.50K(-47.6%)
$44.00K(+10.0%)
$206.00K(-12.7%)
Sep 2014
-
$40.00K(-18.4%)
$236.00K(-9.2%)
Jun 2014
-
$49.00K(-32.9%)
$260.00K(-13.6%)
Mar 2014
-
$73.00K(-1.4%)
$301.00K(-25.1%)
Dec 2013
$402.00K(-47.1%)
$74.00K(+15.6%)
$402.00K(-21.6%)
Sep 2013
-
$64.00K(-28.9%)
$513.00K(-26.6%)
Jun 2013
-
$90.00K(-48.3%)
$699.00K(+14.8%)
Mar 2013
-
$174.00K(-5.9%)
$609.00K(+40.0%)
Dec 2012
$760.00K(-14.2%)
$185.00K(-26.0%)
$435.00K(-97.2%)
Sep 2012
-
$250.00K(-98.4%)
$15.46M(-73.1%)
DateAnnualQuarterlyTTM
Dec 2011
$886.00K(-62.4%)
$15.21M(+1.7%)
$57.52M(+32.3%)
Sep 2011
-
$14.96M(+5.4%)
$43.48M(+50.8%)
Jun 2011
-
$14.20M(+7.9%)
$28.83M(+91.8%)
Mar 2011
-
$13.16M(+1024.5%)
$15.03M(+538.9%)
Dec 2010
$2.35M(-48.2%)
$1.17M(+279.9%)
$2.35M(-61.6%)
Sep 2010
-
$308.00K(-22.6%)
$6.12M(+5.3%)
Jun 2010
-
$398.00K(-16.6%)
$5.81M(+7.3%)
Mar 2010
-
$477.00K(-90.3%)
$5.42M(+1.3%)
Dec 2009
$4.54M(+179.5%)
$4.94M(+1104.8%)
$5.35M(+1204.8%)
Mar 2009
-
$410.00K(+10.2%)
$410.00K(+10.2%)
Dec 2008
$1.63M(+18.7%)
-
-
Mar 2008
-
$372.00K(+81.5%)
$372.00K(+81.5%)
Dec 2007
$1.37M(+66.8%)
-
-
Dec 2006
$821.20K(-5.0%)
-
-
Mar 2006
-
$205.00K(-8.5%)
$205.00K(-8.5%)
Dec 2005
$864.60K(-10.8%)
-
-
Mar 2005
-
$224.00K(-8.2%)
$224.00K(-78.5%)
Dec 2004
$969.40K(-293.9%)
-
-
Mar 2004
-
$244.00K(-1.6%)
$1.04M(-5.4%)
Dec 2003
-
$248.00K(-2.7%)
$1.10M(-5.0%)
Sep 2003
-
$255.00K(-13.3%)
$1.16M(-4.5%)
Jun 2003
-
$294.00K(-3.3%)
$1.21M(-3.9%)
Mar 2003
-
$304.00K(-0.7%)
$1.26M(+1.4%)
Dec 2002
-
$306.00K(-1.3%)
$1.25M(+32.6%)
Sep 2002
-
$310.00K(-9.6%)
$940.00K(+49.2%)
Jun 2002
-
$343.00K(+19.5%)
$630.00K(+119.5%)
Mar 2002
-
$287.00K(+22.1%)
$287.00K(+22.1%)
Mar 2001
-
$235.00K(+51.8%)
$235.00K(+51.8%)
Mar 2000
-
$154.80K(+24.4%)
$154.80K(-58.8%)
Dec 1999
-$500.00K(0.0%)
-
-
Mar 1999
-
$124.40K(+22.0%)
$375.40K(+25.0%)
Dec 1998
-$500.00K(-16.7%)
-
-
Sep 1998
-
$102.00K(-31.5%)
$300.40K(<-9900.0%)
Jun 1998
-
$149.00K(-0.3%)
-$1600.00(-99.5%)
Mar 1998
-
$149.40K(-249.4%)
-$350.60K(-115.2%)
Dec 1997
-$600.00K(+20.0%)
-$100.00K(-50.0%)
$2.30M(0.0%)
Sep 1997
-
-$200.00K(0.0%)
$2.30M(-4.2%)
Jun 1997
-
-$200.00K(-107.1%)
$2.40M(0.0%)
Mar 1997
-
$2.80M(-2900.0%)
$2.40M(-580.0%)
Dec 1996
-$500.00K(-107.7%)
-$100.00K(0.0%)
-$500.00K(-107.7%)
Sep 1996
-
-$100.00K(-50.0%)
$6.50M(0.0%)
Jun 1996
-
-$200.00K(+100.0%)
$6.50M(-1.5%)
Mar 1996
-
-$100.00K(-101.4%)
$6.60M(+1.5%)
Dec 1995
$6.50M(+30.0%)
$6.90M(-7000.0%)
$6.50M(+441.7%)
Sep 1995
-
-$100.00K(0.0%)
$1.20M(-53.8%)
Jun 1995
-
-$100.00K(-50.0%)
$2.60M(-33.3%)
Mar 1995
-
-$200.00K(-112.5%)
$3.90M(-22.0%)
Dec 1994
$5.00M
$1.60M(+23.1%)
$5.00M(+47.1%)
Sep 1994
-
$1.30M(+8.3%)
$3.40M(+61.9%)
Jun 1994
-
$1.20M(+33.3%)
$2.10M(+133.3%)
Mar 1994
-
$900.00K
$900.00K

FAQ

  • What is BioCryst Pharmaceuticals, Inc. annual cost of goods sold?
  • What is the all time high annual cost of goods sold for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. annual cost of goods sold year-on-year change?
  • What is BioCryst Pharmaceuticals, Inc. quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. quarterly cost of goods sold year-on-year change?
  • What is BioCryst Pharmaceuticals, Inc. TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. TTM cost of goods sold year-on-year change?

What is BioCryst Pharmaceuticals, Inc. annual cost of goods sold?

The current annual cost of goods sold of BCRX is $13.73M

What is the all time high annual cost of goods sold for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high annual cost of goods sold is $13.73M

What is BioCryst Pharmaceuticals, Inc. annual cost of goods sold year-on-year change?

Over the past year, BCRX annual cost of goods sold has changed by +$7.42M (+117.40%)

What is BioCryst Pharmaceuticals, Inc. quarterly cost of goods sold?

The current quarterly cost of goods sold of BCRX is $3.13M

What is the all time high quarterly cost of goods sold for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high quarterly cost of goods sold is $15.21M

What is BioCryst Pharmaceuticals, Inc. quarterly cost of goods sold year-on-year change?

Over the past year, BCRX quarterly cost of goods sold has changed by +$1.07M (+52.24%)

What is BioCryst Pharmaceuticals, Inc. TTM cost of goods sold?

The current TTM cost of goods sold of BCRX is $18.00M

What is the all time high TTM cost of goods sold for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high TTM cost of goods sold is $57.52M

What is BioCryst Pharmaceuticals, Inc. TTM cost of goods sold year-on-year change?

Over the past year, BCRX TTM cost of goods sold has changed by +$10.64M (+144.37%)
On this page